Journal article

In vitro Generated Megakaryocytes for the Detection of Human Platelet Antigen-Specific Alloantibodies


Authors listUzun, Guenalp; Lucic, Josip; Marini, Irene; Rigoni, Flavianna; Lyshy, Franziska; Haghighi, Omid; Wolska, Nina; Nowak-Harnau, Stefanie; Althaus, Karina; Sachs, Ulrich J.; Bakchoul, Tamam

Publication year2024

JournalTransfusion Medicine and Hemotherapy

ISSN1660-3796

eISSN1660-3818

Open access statusGold

DOI Linkhttps://doi.org/10.1159/000539617

PublisherKarger Publishers


Abstract
Introduction: Serologic characterization of antihuman platelet antigen (HPA) alloantibodies is crucial in fetal neonatal alloimmune thrombocytopenia. The gold standard MAIPA assay requires fresh platelets from HPA-genotyped donors, which is challenging for some laboratories. Megakaryocytes express HPA epitopes and offer an alternative source for detecting anti-HPA antibodies. The objective of this study was to assess the efficacy of a novel assay called monoclonal antibody immobilization of megakaryocyte antigens (MAIMA) for detecting anti-HPA antibodies. Methods: CD34+ cells from buffy coats were differentiated into megakaryocytes in vitro. The performance of the MAIMA assay was evaluated using WHO reference reagents for HPA-1a, HPA-3a, and HPA-5b, along with sera samples from patients who had well-characterized anti-HPA antibodies. Results: The WHO anti-HPA-1a reference reagent showed similar binding to megakaryocytes and platelets in MAIMA and MAIPA, respectively. On the other hand, optical density (OD) values for the WHO anti-HPA-3a reference reagent were lower in MAIMA than in MAIPA. Anti-HPA-5b antibodies were not detectable in MAIMA. Patients' sera containing anti-HPA-1a antibodies were successfully detected in MAIMA in all clinical samples. Moreover, OD values in MAIPA and MAIMA showed high correlation (r = 0.96, p < 0.001). MAIMA was reactive for samples with anti-HPA-3a as well as anti-HPA-3b; however, OD values were lower compared to MAIPA. Interestingly, all patient samples with anti-HPA-5b antibodies were tested negative in MAIMA. Conclusion: In vitro generated megakaryocytes can be used to detect anti-HPA-1a alloantibodies. However, despite this potential, they may be less suitable for the detection of alloantibodies against other HPAs such as HPA-5b. (c) 2024 The Author(s).Published by S. Karger AG, Basel.



Citation Styles

Harvard Citation styleUzun, G., Lucic, J., Marini, I., Rigoni, F., Lyshy, F., Haghighi, O., et al. (2024) In vitro Generated Megakaryocytes for the Detection of Human Platelet Antigen-Specific Alloantibodies, Transfusion Medicine and Hemotherapy. https://doi.org/10.1159/000539617

APA Citation styleUzun, G., Lucic, J., Marini, I., Rigoni, F., Lyshy, F., Haghighi, O., Wolska, N., Nowak-Harnau, S., Althaus, K., Sachs, U., & Bakchoul, T. (2024). In vitro Generated Megakaryocytes for the Detection of Human Platelet Antigen-Specific Alloantibodies. Transfusion Medicine and Hemotherapy. https://doi.org/10.1159/000539617



Keywords


ALLOANTIGENSAMINO-ACID POLYMORPHISMBuffy coatFETALFetal alloimmune thrombocytopeniaNEONATAL ALLOIMMUNE THROMBOCYTOPENIAPlatelet antigens

Last updated on 2025-10-06 at 12:09